Verition Fund Management »

Atea Pharmaceuticals shares owned by Verition Fund Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $218k 66k 3.31
2023-09-30 $69k 23k 3.00
2021-06-30 $309k 14k 21.50